Global MerTK Inhibitors Market Overview
MerTK (MER tyrosine kinase) has been found to be expressed in a number of cancers, including leukaemia, melanoma, and gastric cancer (GC). MerTK is a key player in the oncogenesis pathway. MerTK is a potential therapeutic target that is ectopically expressed in 30 to 50 percent of acute lymphoblastic leukemias (ALL) and more than 80 percent of acute myeloid leukemias (AML). Mer belongs to the TAM (TYRO3-AXL-MER) family of receptor tyrosine kinases, which govern tumour cell survival, proliferation, migration, and invasion, as well as tumor-host interactions when active. Innate immune activation is also triggered via the MerTK pathway. A growing amount of evidence suggests that these receptors play a significant role in resistance to targeted medicines and traditional cytotoxic drugs. In macrophages, dendritic cells, and other immune cells, MerTK has been identified as an immunological checkpoint. The MerTK Inhibitors Market accounted for US$ 280.719 Million in 2020 and is estimated to be US$ 558.8 Million by 2030 and is anticipated to register a CAGR of 7.1%.
Global MerTK Inhibitors Market Dynamics
Growth in business operations by emerging and small sized players
MerTK is gaining traction as a potential cancer therapeutic target. During the forecast period, the MerTK inhibitors market is anticipated to be propelled by ongoing clinical trials and studies on MerTK inhibitors as a new cancer therapeutic option. The increasing focus on new research by government bodies and key companies is a fundamental driver driving global market expansion. The global MerTK inhibitors market is growing due to an increase in the number of people suffering from various health problems.
Global MerTK Inhibitors Market Segmentation
Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.
The global MerTK Inhibitors market is segmented based on role of process, phase, end-user, and region.
On the basis of Role of process, the global MerTK inhibitors market is segmented into Macrophage clearance of apoptotic cells, Platelet aggregation, Cytoskeleton reorganization, Engulfment and Others. Based on Phase, the target market is segmented into Phase I, Phase II and Others. On the basis of End-user, the target market is segmented into Specialty Clinics, Research & laboratories and Others.
Regional Insights:
On region the global MerTK inhibitors market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global MerTk Inhibitors market for the upcoming forecast period. This is mainly due to the increased demand for better healthcare.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Role of process- Macrophage clearance of apoptotic cells, Platelet aggregation, Cytoskeleton reorganization, Engulfment and Others By Phase– Phase I, Phase II and Others By End-user– Specialty Clinics, Research and laboratories and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global MerTK inhibitors market report based on role of process, phase, end-user, and region.
Global MerTK Inhibitors Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global MerTK Inhibitors Market Key Players
The key players operating in the global MerTK Inhibitors market includes Celon Pharma SA, Dong-A Socio Holdings Co Ltd, Eli Lilly and Co, Elsalys Biotech SA, F. Hoffmann-La Roche Ltd, HEC Pharm Co Ltd, Hope Biosciences Inc., Incyte Corp, Meryx Inc., Novithera SAS, Ono Pharmaceutical Co Ltd, Qurient Co Ltd, Rgenix Inc., Signal Chem Lifesciences Corp and TamRx LLC.
Global MerTK Inhibitors Market Company Profile
- Eli Lilly and Co.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Celon Pharma SA
- Dong-A Socio Holdings Co Ltd
- Elsalys Biotech SA
- F. Hoffmann-La Roche Ltd
- HEC Pharm Co Ltd
- Hope Biosciences Inc.
- Incyte Corp
- Meryx Inc.
- Novithera SAS
- Ono Pharmaceutical Co Ltd
- Qurient Co Ltd
- Rgenix Inc.
- Signal Chem Lifesciences Corp
- TamRx LLC.
“*” marked represents similar segmentation in other categories in the respective section
Global MerTK Inhibitors Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for MerTK Inhibitors Strategies
- Key Questions this Study will Answer
- Market Snippet, By Role of process
- Market Snippet, By Phase
- Market Snippet, By End-User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global MerTK Inhibitors Market, By Role of process, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Macrophage clearance of apoptotic cells
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Platelet aggregation
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Cytoskeleton reorganization
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Engulfment
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global MerTK Inhibitors Market, By Phase, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Phase I
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Phase II
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global MerTK Inhibitors Market, By End-User, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Specialty Clinics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Research & Laboratories
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global MerTK Inhibitors Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Role of process, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Role of process, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Role of process, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Role of process, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Role of process, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Eli Lilly and Co.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Celon Pharma SA
- Dong-A Socio Holdings Co Ltd
- Elsalys Biotech SA
- F. Hoffmann-La Roche Ltd
- HEC Pharm Co Ltd
- Hope Biosciences Inc.
- Incyte Corp
- Meryx Inc.
- Novithera SAS
- Ono Pharmaceutical Co Ltd
- Qurient Co Ltd
- Rgenix Inc.
- Signal Chem Lifesciences Corp
- TamRx LLC.
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
The global MerTK inhibitors market is segmented based on role of process, phase, end-user, and region.
The increasing focus on new research by government bodies and key companies is a fundamental driver driving global market expansion.
North America is expected to dominate the global MerTk Inhibitors market for the upcoming forecast period. This is mainly due to the increased demand for better healthcare.
Companies are continuously focusing on new research and launches, also they are collaborating with each other, which is increasing the market growth.